1. SARS-CoV-2 infects neurons and induces neuroinflammation in a non-human primate model of COVID-19
- Author
-
Beckman, Danielle, Bonillas, Alyssa, Diniz, Giovanne B, Ott, Sean, Roh, Jamin W, Elizaldi, Sonny R, Schmidt, Brian A, Sammak, Rebecca L, Van Rompay, Koen KA, Iyer, Smita S, and Morrison, John H
- Subjects
Biological Sciences ,Infectious Diseases ,Coronaviruses ,Emerging Infectious Diseases ,Lung ,Neurosciences ,Brain Disorders ,Neurological ,Good Health and Well Being ,Animals ,SARS-CoV-2 ,COVID-19 ,Neuroinflammatory Diseases ,Nervous System Diseases ,Neurons ,Primates ,CP: Microbiology ,CP: Neuroscience ,NHP ,astrocytes ,coronavirus ,macaque ,microglia ,neurotropism ,rhesus ,neuroinflammation ,high-resolution microscopy ,Biochemistry and Cell Biology ,Medical Physiology ,Biological sciences - Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiologic agent of coronavirus disease 2019 (COVID-19), can induce a plethora of neurological complications in some patients. However, it is still under debate whether SARS-CoV-2 directly infects the brain or whether CNS sequelae result from systemic inflammatory responses triggered in the periphery. By using high-resolution microscopy, we investigated whether SARS-CoV-2 reaches the brain and how viral neurotropism can be modulated by aging in a non-human primate model of COVID-19. Seven days after infection, SARS-CoV-2 was detected in the olfactory cortex and interconnected regions and was accompanied by robust neuroinflammation and neuronal damage exacerbated in aged, diabetic animals. Our study provides an initial framework for identifying the molecular and cellular mechanisms underlying SARS-CoV-2 neurological complications, which will be essential to reducing both the short- and long-term burden of COVID-19.
- Published
- 2022